Compelling evidence that exposure therapy for PTSD normalizes brain function

Michael J. Roy, Michelle E. Costanzo, James R. Blair, Albert A. Rizzo

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Functional magnetic resonance imaging (fMRI) is helping us better understand the neurologic pathways involved in posttraumatic stress disorder (PTSD). We previously reported that military service members with PTSD after deployment to Iraq or Afghanistan demonstrated significant improvement, or normalization, in the fMRI-measured activation of the amygdala, prefrontal cortex and anterior cingulate gyrus following exposure therapy for PTSD. However, our original study design did not include repeat scans of control participants, rendering it difficult to discern how much of the observed normalization in brain activity is attributable to treatment, rather than merely a practice effect. Using the same Affective Stroop task paradigm, we now report on a larger sample of PTSD-positive combat veterans that we treated with exposure therapy, as well as a combat-exposed control group of service members who completed repeat scans at 3-4 month intervals. Findings from the treatment group are similar to our prior report. Combat controls showed no significant change on repeat scanning, indicating that the observed differences in the intervention group were in fact due to treatment. We continue to scan additional study participants, in order to determine whether virtual reality exposure therapy has a different impact on regional brain activation than other therapies for PTSD.

Original languageEnglish (US)
Pages (from-to)61-65
Number of pages5
JournalStudies in Health Technology and Informatics
Volume199
DOIs
StatePublished - 2014

Fingerprint

Implosive Therapy
Post-Traumatic Stress Disorders
Brain
Chemical activation
Virtual Reality Exposure Therapy
Virtual reality
Magnetic Resonance Imaging
Stroop Test
Afghanistan
Iraq
Gyrus Cinguli
Scanning
Veterans
Therapeutics
Amygdala
Prefrontal Cortex
Nervous System
Control Groups

Keywords

  • Vrtual reality
  • combat stress
  • exposure therapy
  • functional magnetic resonance imaging
  • posttraumatic stress

ASJC Scopus subject areas

  • Biomedical Engineering
  • Health Informatics
  • Health Information Management

Cite this

Compelling evidence that exposure therapy for PTSD normalizes brain function. / Roy, Michael J.; Costanzo, Michelle E.; Blair, James R.; Rizzo, Albert A.

In: Studies in Health Technology and Informatics, Vol. 199, 2014, p. 61-65.

Research output: Contribution to journalArticle

Roy, Michael J. ; Costanzo, Michelle E. ; Blair, James R. ; Rizzo, Albert A. / Compelling evidence that exposure therapy for PTSD normalizes brain function. In: Studies in Health Technology and Informatics. 2014 ; Vol. 199. pp. 61-65.
@article{a08d4710b2f0483a8985cb2e6fada5b2,
title = "Compelling evidence that exposure therapy for PTSD normalizes brain function",
abstract = "Functional magnetic resonance imaging (fMRI) is helping us better understand the neurologic pathways involved in posttraumatic stress disorder (PTSD). We previously reported that military service members with PTSD after deployment to Iraq or Afghanistan demonstrated significant improvement, or normalization, in the fMRI-measured activation of the amygdala, prefrontal cortex and anterior cingulate gyrus following exposure therapy for PTSD. However, our original study design did not include repeat scans of control participants, rendering it difficult to discern how much of the observed normalization in brain activity is attributable to treatment, rather than merely a practice effect. Using the same Affective Stroop task paradigm, we now report on a larger sample of PTSD-positive combat veterans that we treated with exposure therapy, as well as a combat-exposed control group of service members who completed repeat scans at 3-4 month intervals. Findings from the treatment group are similar to our prior report. Combat controls showed no significant change on repeat scanning, indicating that the observed differences in the intervention group were in fact due to treatment. We continue to scan additional study participants, in order to determine whether virtual reality exposure therapy has a different impact on regional brain activation than other therapies for PTSD.",
keywords = "Vrtual reality, combat stress, exposure therapy, functional magnetic resonance imaging, posttraumatic stress",
author = "Roy, {Michael J.} and Costanzo, {Michelle E.} and Blair, {James R.} and Rizzo, {Albert A.}",
year = "2014",
doi = "10.3233/978-1-61499-401-5-61",
language = "English (US)",
volume = "199",
pages = "61--65",
journal = "Studies in Health Technology and Informatics",
issn = "0926-9630",
publisher = "IOS Press",

}

TY - JOUR

T1 - Compelling evidence that exposure therapy for PTSD normalizes brain function

AU - Roy, Michael J.

AU - Costanzo, Michelle E.

AU - Blair, James R.

AU - Rizzo, Albert A.

PY - 2014

Y1 - 2014

N2 - Functional magnetic resonance imaging (fMRI) is helping us better understand the neurologic pathways involved in posttraumatic stress disorder (PTSD). We previously reported that military service members with PTSD after deployment to Iraq or Afghanistan demonstrated significant improvement, or normalization, in the fMRI-measured activation of the amygdala, prefrontal cortex and anterior cingulate gyrus following exposure therapy for PTSD. However, our original study design did not include repeat scans of control participants, rendering it difficult to discern how much of the observed normalization in brain activity is attributable to treatment, rather than merely a practice effect. Using the same Affective Stroop task paradigm, we now report on a larger sample of PTSD-positive combat veterans that we treated with exposure therapy, as well as a combat-exposed control group of service members who completed repeat scans at 3-4 month intervals. Findings from the treatment group are similar to our prior report. Combat controls showed no significant change on repeat scanning, indicating that the observed differences in the intervention group were in fact due to treatment. We continue to scan additional study participants, in order to determine whether virtual reality exposure therapy has a different impact on regional brain activation than other therapies for PTSD.

AB - Functional magnetic resonance imaging (fMRI) is helping us better understand the neurologic pathways involved in posttraumatic stress disorder (PTSD). We previously reported that military service members with PTSD after deployment to Iraq or Afghanistan demonstrated significant improvement, or normalization, in the fMRI-measured activation of the amygdala, prefrontal cortex and anterior cingulate gyrus following exposure therapy for PTSD. However, our original study design did not include repeat scans of control participants, rendering it difficult to discern how much of the observed normalization in brain activity is attributable to treatment, rather than merely a practice effect. Using the same Affective Stroop task paradigm, we now report on a larger sample of PTSD-positive combat veterans that we treated with exposure therapy, as well as a combat-exposed control group of service members who completed repeat scans at 3-4 month intervals. Findings from the treatment group are similar to our prior report. Combat controls showed no significant change on repeat scanning, indicating that the observed differences in the intervention group were in fact due to treatment. We continue to scan additional study participants, in order to determine whether virtual reality exposure therapy has a different impact on regional brain activation than other therapies for PTSD.

KW - Vrtual reality

KW - combat stress

KW - exposure therapy

KW - functional magnetic resonance imaging

KW - posttraumatic stress

UR - http://www.scopus.com/inward/record.url?scp=84903149862&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84903149862&partnerID=8YFLogxK

U2 - 10.3233/978-1-61499-401-5-61

DO - 10.3233/978-1-61499-401-5-61

M3 - Article

C2 - 24875691

AN - SCOPUS:84903149862

VL - 199

SP - 61

EP - 65

JO - Studies in Health Technology and Informatics

JF - Studies in Health Technology and Informatics

SN - 0926-9630

ER -